Aminologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31,478	26,456	18,882	11,999	12,738	8,861
Short-Term Investments	26,500	26,500	16,500	16,500	16,500	16,500
Trading Asset Securities	10,147	10,076	-	-	-	302.04
Cash & Short-Term Investments	68,125	63,032	35,382	28,499	29,238	25,663
Cash Growth	76.22%	78.14%	24.15%	-2.53%	13.93%	1.10%
Accounts Receivable	5,307	7,465	4,498	8,241	5,384	6,334
Other Receivables	384.71	249.38	151.8	175.94	260.15	155.36
Receivables	5,691	7,714	4,650	8,417	5,644	6,489
Inventory	4,810	4,440	6,083	7,977	8,335	6,373
Prepaid Expenses	262.22	150	213.72	189.9	285.58	83.86
Other Current Assets	3,340	3,274	188.02	166.43	66.39	69.7
Total Current Assets	82,229	78,610	46,517	45,249	43,569	38,679
Property, Plant & Equipment	2,529	2,612	3,090	2,630	2,826	2,120
Long-Term Investments	631.28	714.11	3,905	4,988	4,368	5,101
Other Intangible Assets	1,996	1,998	3,046	4,054	4,074	17,598
Long-Term Deferred Tax Assets	-	-	-	515.44	520.95	1,522
Other Long-Term Assets	244.52	244.02	231.23	231.48	224.05	221.75
Total Assets	87,631	84,178	56,789	57,668	55,582	65,243
Accounts Payable	2,406	837.74	2,459	648.71	1,550	3,674
Accrued Expenses	342.39	320.1	288.89	247.74	207.15	159.36
Short-Term Debt	15,927	15,449	1,000	1,000	1,000	1,000
Current Portion of Leases	162.26	196.13	283.66	229.42	239.59	185.74
Other Current Liabilities	11,087	10,773	310.79	541.65	431.99	362.01
Total Current Liabilities	29,925	27,576	4,342	2,668	3,429	5,381
Long-Term Leases	550.8	569.02	734.77	589.53	749.49	468.03
Long-Term Unearned Revenue	40.89	39.53	17.12	-	-	-
Other Long-Term Liabilities	-0	-0	-0	-	0	-
Total Liabilities	30,517	28,185	5,094	3,257	4,178	5,849
Common Stock	8,783	8,783	8,783	8,783	8,783	8,783
Additional Paid-In Capital	118,400	118,400	118,400	118,400	118,400	118,400
Retained Earnings	-68,705	-69,772	-73,997	-72,377	-74,814	-67,532
Comprehensive Income & Other	-1,364	-1,417	-1,490	-394.49	-965.24	-257.89
Shareholders' Equity	57,114	55,994	51,695	54,411	51,404	59,393
Total Liabilities & Equity	87,631	84,178	56,789	57,668	55,582	65,243
Total Debt	16,640	16,214	2,018	1,819	1,989	1,654
Net Cash (Debt)	51,486	46,817	33,364	26,680	27,249	24,010
Net Cash Growth	40.29%	40.32%	25.05%	-2.09%	13.49%	1.29%
Net Cash Per Share	581.83	533.07	370.70	303.78	310.26	273.38
Filing Date Shares Outstanding	88.95	87.83	87.83	87.83	87.83	87.83
Total Common Shares Outstanding	88.95	87.83	87.83	87.83	87.83	87.83
Working Capital	52,304	51,034	42,175	42,581	40,140	33,298
Book Value Per Share	642.11	637.54	588.61	619.53	585.29	676.25
Tangible Book Value	55,118	53,996	48,649	50,357	47,330	41,795
Tangible Book Value Per Share	619.67	614.80	553.92	573.36	538.90	475.88
Land	281.84	281.84	281.84	281.84	281.84	281.84
Buildings	840.38	840.38	840.38	840.38	840.38	840.38
Machinery	7,669	7,622	7,584	7,033	6,864	6,349